This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Stocks That Insiders Love Right Now

Clovis Oncology

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Insiders have been doing some decent buying in development-stage biopharmaceutical player Clovis Oncology (CLVS). Insiders are loading up on this stock into strength since shares are up over 33% so far in 2012.

Clovis Oncology has a market cap of $484 million and an enterprise value of $329 million. Its estimated growth rate for this year is 78.4%, and for next year it's pegged at -37.2%. This is a cash-rich company, since the total cash position on its balance sheet is $140.25 million and its total debt is zero.

A director just bought 25,000 shares, or $500,000 worth of stock, at $20.00 per share. This company also just announced a secondary offering of 3.75 million shares of common stock priced at $20 per share.

>>10 Stocks That Could Rise in Market Decline

From a technical perspective, CLVS is currently trading below its 50-day moving average, which is bearish. This stock IPOed back in November of last year, and since then it's soared from a low of $11.45 to a recent high of $27.55 a share. After hitting that high, the stock has dropped sharply with high-volume back below its 50-day to a recent low of $17.85.

If you're a bull on CLVS, I would only look for long-biased trades once this stock breaks out above some near-term overhead resistance at $19.20 to $20.50 a share with high volume. Look for volume on that move that's near or well above its three-month average action of 110,405 shares. It's worth pointing out that volume on Wednesday was 140,290 shares and the stock finished near its daily high of $19 a share. If we get that action soon, then this stock has a great chance to make a quick run at its 50-day moving average of $23.08 or possibly higher.

I would avoid any long trades in CLVS if this stock drops back below its recent low of $17.85 with volume. The downside could be big if CLVS loses that level since the next major support zone won't come into play until around $15 to $13 a share.

2 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs